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The Impact of Free Health Screenings at 
Community Pharmacies on Diabetes
Anna Smith, Jacques Allou, Jeniffer George, Jessica Amtower, and Nicholas Daniels
Emily Laswell, PharmD. and Jeb Ballentine, PharmD.
Cedarville University, School of Pharmacy, Cedarville, OH 45314
STATEMENT OF THE PROBLEM
Background
Health screenings can be very important and beneficial to individuals to detect 
diseases early on so they can be treated more easily.1  These screenings can 
be performed at community pharmacies, which is convenient because an 
appointment is not needed and these locations are easily accessible to 
patients.2  Currently, an estimated 7 million Americans may be undiagnosed 
with diabetes, making it one of the most significant health issues faced today.  
Without treatment, the disease could become worse and also lead to other 
more serious health issues.3 Having health screenings in community 
pharmacies could be valuable in detecting diabetes in order to be referred for 
diagnosis and treatment.  Previous studies related to health screenings have 
focused on hypertension and cholesterol, and few have been conducted on 
diabetes alone.  There has not been extensive research performed regarding 
patient knowledge of diabetes or on the impact of health screenings in general.  
Due to this lack of research and the prevalence of diabetes, it is essential to 
explore the impact of free health screenings in regards to this growing 
healthcare issue.
Significance of the Problem
•Approximately 26 million people (8.3% of the population) just in the United 
States are affected by diabetes
•Diabetes contributed to 231,404 deaths in just 2007 alone
•Diabetes can lead to heart disease, stroke, kidney failure, and neuropathy4
To assess the impact of free health screenings in community pharmacies 
on patient follow-up, perceptions, and knowledge of diabetes through blood 
glucose screenings and patient education.
OBJECTIVES
Quantitative
• SPSS software
• Comparing pre-survey and post-survey patient perceptions using 
Wilcoxon signed rank test
• Comparing pre-survey and post-survey patient diabetes knowledge 
using paired t-test
• Descriptive statistics on number and percent of people referred that do 
and do not see their physician and that are diagnosed with diabetes
• Comparing groups of diagnosed to undiagnosed patients using chi-
square test
PROPOSED METHODS
PROPOSED ANALAYSES
.
• No reliable way of making sure patients have not been previously 
diagnosed with diabetes
• Testing was only done at local community pharmacies
LIMITATIONS
PROJECT TIMELINE
Study Design
•Pretest and post-tests will be given at baseline regarding patient perceptions on 
health screenings and diabetes knowledge
•Pretests will be given at baseline before blood glucose testing and diabetes 
education
•Post-tests will be given a month after blood glucose testing and diabetes education
•Patients will be called a month after the pretest regarding referral and potential 
diabetes diagnosis
Sample
•Purposive sampling at local Kroger pharmacies
•Inclusion criteria
o Ages 18 and above
o Patients not previously diagnosed with diabetes
o Patients not recently tested for diabetes
•Exclusion criteria
o Patients with learning disabilities that would hinder pre- and post-survey 
knowledge assessments
o Patients on any medications that could cause hyperglycemia
Data Collection
•Data will be recorded by hand on a patient record sheet
•Surveys will be administered on paper
Measurement
•Surveys will measure patient perceptions on health screenings and patient 
knowledge of diabetes
•Patient record sheets will measure referrals
•Phone calls will measure patient compliance to referrals and number of patients 
diagnosed with diabetes
HYPOTHESES
H0: Blood glucose screenings and patient education on diabetes do not 
affect patient follow-up, increase patient knowledge of diabetes, or improve 
patient perceptions of health screenings.
HA:  Blood glucose screenings and patient education on diabetes affect 
patient follow-up, increase patient knowledge of diabetes, and improve 
patient perceptions of health screenings.
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FUTURE DIRECTIONS
Data collection 
begins 
Summer of 
2014
Data collection 
ends Summer 
of 2015
Analysis of 
data in Winter 
of 2015
Presentation 
of findings in 
Spring of 2016
